IPCALABNSEIPCA Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Mon, 7 Jul · 18:27 IST

IPCA Laboratories Limited has informed the Exchange about Credit Rating

Debt PrepaidCredit & Debt View source PDF

IPCALAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

India Ratings & Research (Fitch Group) has affirmed all credit ratings for Ipca Laboratories, maintaining the strong investment-grade profile. The company's working capital limit (INR 20,150 million) and commercial paper (INR 500 million) were affirmed at IND AA+/Stable and IND A1+ respectively. Long-term loan was reaffirmed at IND AA+/Stable, though the size was reduced from INR 5,185.6 million to INR 3,787.3 million, indicating partial debt prepayment. A new proposed long-term loan of INR 2,000 million was also affirmed at IND AA+/Stable.

Likely market impact

Affirmation of AA+ rating with stable outlook signals continued financial strength and low default risk, which is positive for shareholders. The reduction in existing long-term loan size suggests deleveraging, while the new proposed facility provides additional funding flexibility for growth.